Potential antibody treatment for yellow fever developed in 7 months using Rapid Response Strategy – News-Medical.net

Yellow fever, an acute viral hemorrhagic disease transmitted by infected mosquitoes, infects about 200,000 people and causes an estimated 30,000 deaths each year. While currently endemic in 47 countries in Africa and Central and South America, the potential for large urban outbreaks is still present in other regions where the mosquitoes capable of transmitting yellow fever exist, especially in Southeast Asia due to the favorable ecology for the Aedes aegypti mosquito species. This is particularl…

Click here to view the original article.